Timeline of incretin therapeutics: difference between revisions
Diff·revision 16 → 17·21:02, 28 May 2025
Difference between revision 16 and revision 17 of Timeline of incretin therapeutics. 1 line changed; the page grew by 38 bytes.
| Revision 16 — 08:42, 30 Apr 2025 SurvodutideSaff (talk) the lead claimed weekly dosing for a compound dosed daily; corrected 3,954 bytes ±0 | Revision 17 — 21:02, 28 May 2025 BaselineBex (talk) expand §Physiology 3,992 bytes +38 | ||
|---|---|---|---|
| 64 | * [[Tirzepatide]] | 64 | * [[Tirzepatide]] |
| 65 | * [[SELECT trial]] | 65 | * [[SELECT trial]] |
| + | 66 | * [[List of GLP-1 receptor agonists]] | |
| 66 | 67 | ||
| 67 | {{DEFAULTSORT:Timeline of incretin therapeutics}} | 68 | {{DEFAULTSORT:Timeline of incretin therapeutics}} |